BARODA BNP PARIBAS HEALTH AND WELLNESS FUND REGULAR PLAN IDCW REINVESTMENT - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of March 31, 2026
Asset Allocation
Equity: 95.92%Others: 4.08%
Market Cap
Large Cap: 26.48%Mid Cap: 33.90%Small Cap: 32.33%Others: 3.21%
Number of stocks
32
Top 10 Holdings
52.23% of portfolio
Market Cap of Equity
Large Cap
26.48%
Mid Cap
33.90%
Small Cap
32.33%
Others
3.21%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd10.23%
Lupin Ltd6.29%
Abbott India Ltd5.53%
Torrent Pharmaceuticals Ltd5.32%
Ipca Laboratories Ltd5.28%
Laurus Labs Ltd4.43%
J.B. Chemicals & Pharmaceuticals Ltd4.41%
AstraZeneca Pharma India Ltd3.92%
SBI Life Insurance Co Ltd3.45%
Emcure Pharmaceuticals Ltd3.36%
Sector Allocation of Equity
Healthcare87.87%
Financial Services6.32%
Basic Materials1.74%
SIP Amount
Monthly SIP Date
BARODA BNP PARIBAS HEALTH AND WELLNESS FUND REGULAR PLAN IDCW REINVESTMENT


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.